TY - JOUR
T1 - Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
AU - Winter, Elizabeth
AU - Dekkers, Olaf
AU - Andreasen, Caroline
AU - D'Angelo, Salvatore
AU - Appelman-Dijkstra, Natasha
AU - Appenzeller, Simone
AU - Assmann, Gunter
AU - Bubbear, Judith
AU - Bulaicon, Oana
AU - Chapurlat, Roland
AU - Choida, Varvara
AU - Clunie, Gavin P.R.
AU - Daoussis, Dimitrios
AU - Diekhoff, Torsten
AU - Flendrie, Marcel
AU - Fogel, Olivier
AU - Ghossan, Roba
AU - Girschick, Hermann
AU - van Haalen, Femke
AU - Hamdy, Neveen
AU - Hauser, Barbara
AU - Hedrich, Christian
AU - Helliwell, Philip
AU - Hermann, Kay Geert
AU - Insalaco, Antonella
AU - Jurik, Anne Grethe
AU - Kishimoto, Mitsumasa
AU - Lems, Willem
AU - Miettunen, Paivi
AU - Muche, Burkhard
AU - Cañete, Ana Navas
AU - Palmou-Fontana, Natalia
AU - Smit, Frits
AU - Teh, James
AU - Verroken, Charlotte
AU - de Vlam, Kurt
AU - Wendling, Daniel
AU - Zhou, Wei
AU - Zmierczak, Hans Georg
AU - Leerling, Anne
PY - 2025/2
Y1 - 2025/2
N2 - Background: There is considerable practice variation in labelling, diagnosis and treatment of adults with sterile bone inflammation. We developed a expert consensus recommendations on the disease definition, diagnosis and treatment of this rare condition. Methods: Systematic literature review and Grading of Recommendations, Assessment, Development and Evaluations-based appraisal of evidence, two Delphi surveys and three digital and in-person consensus meetings with a multidisciplinary expert panel and patient representatives. Results: A consensus disease definition was developed and the term ’chronic non-bacterial osteitis’ (CNO) is proposed to describe adults with sterile bone inflammation. For initial imaging evaluation of adults with suspected CNO, the panel recommends MRI or otherwise CT combined with nuclear imaging. Whole-body imaging at initial evaluation can be considered for diagnostic and prognostic purposes. Suggested first-line treatment in adults with active CNO includes nonsteroidal anti-inflammatory drugs/cyclooxygenase 2-inhibitors. Second-line treatment preferably consists of intravenous bisphosphonates, and otherwise tumour necrosis factor-α inhibitors. Choice between them should be individualised, considering the presence of additional inflammatory features. The panel further discusses outcome measures, follow-up and management of adverse events and complications. Conclusions and future perspectives: These expert consensus recommendations are intended to support healthcare professionals worldwide in their care for adults with CNO. They also lay the groundwork for establishing international patient registries, translational research lines and multicentre trials, all of which are urgently required.
AB - Background: There is considerable practice variation in labelling, diagnosis and treatment of adults with sterile bone inflammation. We developed a expert consensus recommendations on the disease definition, diagnosis and treatment of this rare condition. Methods: Systematic literature review and Grading of Recommendations, Assessment, Development and Evaluations-based appraisal of evidence, two Delphi surveys and three digital and in-person consensus meetings with a multidisciplinary expert panel and patient representatives. Results: A consensus disease definition was developed and the term ’chronic non-bacterial osteitis’ (CNO) is proposed to describe adults with sterile bone inflammation. For initial imaging evaluation of adults with suspected CNO, the panel recommends MRI or otherwise CT combined with nuclear imaging. Whole-body imaging at initial evaluation can be considered for diagnostic and prognostic purposes. Suggested first-line treatment in adults with active CNO includes nonsteroidal anti-inflammatory drugs/cyclooxygenase 2-inhibitors. Second-line treatment preferably consists of intravenous bisphosphonates, and otherwise tumour necrosis factor-α inhibitors. Choice between them should be individualised, considering the presence of additional inflammatory features. The panel further discusses outcome measures, follow-up and management of adverse events and complications. Conclusions and future perspectives: These expert consensus recommendations are intended to support healthcare professionals worldwide in their care for adults with CNO. They also lay the groundwork for establishing international patient registries, translational research lines and multicentre trials, all of which are urgently required.
KW - epidemiology
KW - health care
KW - magnetic resonance imaging
KW - outcome and process assessment
KW - tumor necrosis factors
UR - http://www.scopus.com/inward/record.url?scp=85213689810&partnerID=8YFLogxK
U2 - 10.1136/ard-2024-226446
DO - 10.1136/ard-2024-226446
M3 - Journal article
C2 - 39608805
AN - SCOPUS:85213689810
SN - 0003-4967
VL - 84
SP - 169
EP - 187
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
IS - 2
ER -